Confined Copper Depletion via a Hydrogel Platform for Reversing Dabrafenib/Cetuximab Resistance in BRAF^V600E-Mutant Colorectal Cancer

Scientists developed a hydrogel platform for confined copper depletion in BRAFV600E-mutant colorectal cancer cells, which effectively reversed dabrafenib/cetuximab resistance and enhancing therapeutic efficiency.